Nomura Asset Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.9M Buy
65,232
+995
+2% +$501K 0.08% 249
2025
Q4
$30M Buy
64,237
+3,724
+6% +$1.73M 0.08% 249
2025
Q3
$25.8M Sell
60,513
-611
-1% -$237K 0.07% 273
2025
Q2
$23.4M Buy
61,124
+1,574
+3% +$567K 0.06% 279
2025
Q1
$20.6M Buy
59,550
+1,915
+3% +$616K 0.06% 286
2024
Q4
$17.3M Sell
57,635
-763
-1% -$267K 0.05% 308
2024
Q3
$23.7M Sell
58,398
-7,280
-11% -$2.67M 0.07% 247
2024
Q2
$21.1M Sell
65,678
-6,083
-8% -$1.98M 0.07% 244
2024
Q1
$23.9M Buy
71,761
+9,228
+15% +$2.82M 0.09% 232
2023
Q4
$16.9M Buy
62,533
+9,411
+18% +$2.33M 0.07% 268
2023
Q3
$13.1M Sell
53,122
-962
-2% -$263K 0.06% 295
2023
Q2
$16.4M Sell
54,084
-808
-1% -$225K 0.08% 263
2023
Q1
$14.5M Sell
54,892
-1,560
-3% -$396K 0.08% 270
2022
Q4
$13.5M Buy
56,452
+603
+1% +$135K 0.08% 272
2022
Q3
$10.3M Sell
55,849
-15,707
-22% -$3.13M 0.07% 306
2022
Q2
$12M Buy
71,556
+1,107
+2% +$238K 0.08% 272
2022
Q1
$17.7M Buy
70,449
+16,522
+31% +$4.15M 0.1% 224
2021
Q4
$13.9M Sell
53,927
-834
-2% -$204K 0.07% 264
2021
Q3
$13.3M Buy
54,761
+1,520
+3% +$372K 0.08% 262
2021
Q2
$11M Buy
53,241
+1,854
+4% +$378K 0.06% 295
2021
Q1
$9.68M Buy
51,387
+991
+2% +$175K 0.06% 304
2020
Q4
$8.29M Buy
50,396
+1,980
+4% +$290K 0.06% 302
2020
Q3
$6.04M Sell
48,416
-246
-0.5% -$30.4K 0.05% 332
2020
Q2
$4.72M Sell
48,662
-840
-2% -$87.3K 0.04% 369
2020
Q1
$4.45M Buy
49,502
+3,184
+7% +$412K 0.05% 329
2019
Q4
$6.85M Sell
46,318
-2,208
-5% -$297K 0.06% 290
2019
Q3
$5.84M Buy
48,526
+2,614
+6% +$338K 0.06% 297
2019
Q2
$6.21M Sell
45,912
-372
-0.8% -$47K 0.06% 281
2019
Q1
$6.03M Sell
46,284
-2,503
-5% -$336K 0.06% 283
2018
Q4
$6.07M Buy
48,787
+3,599
+8% +$483K 0.07% 255
2018
Q3
$6.29M Buy
45,188
+1,630
+4% +$203K 0.06% 263
2018
Q2
$4.47M Buy
43,558
+140
+0.3% +$14.2K 0.05% 316
2018
Q1
$4.21M Buy
43,418
+1,970
+5% +$191K 0.05% 312
2017
Q4
$3.64M Buy
41,448
+30
+0.1% +$2.41K 0.04% 350
2017
Q3
$3.3M Sell
41,418
-11,148
-21% -$897K 0.04% 351
2017
Q2
$4.58M Buy
52,566
+80
+0.2% +$6.77K 0.06% 281
2017
Q1
$4.67M Sell
52,486
-176
-0.3% -$14.7K 0.07% 277
2016
Q4
$3.9M Sell
52,662
-8,609
-14% -$645K 0.07% 286
2016
Q3
$4.63M Buy
61,271
+8,655
+16% +$663K 0.08% 250
2016
Q2
$4.05M Buy
52,616
+10,199
+24% +$805K 0.08% 263
2016
Q1
$3.31M Sell
42,417
-5,680
-12% -$397K 0.06% 290
2015
Q4
$3.25M Buy
48,097
+800
+2% +$55.8K 0.06% 290
2015
Q3
$3.66M Buy
47,297
+587
+1% +$52K 0.07% 258
2015
Q2
$4.24M Buy
46,710
+2,140
+5% +$171K 0.08% 247
2015
Q1
$3.35M Sell
44,570
-6,000
-12% -$431K 0.06% 282
2014
Q4
$3.73M Sell
50,570
-1,900
-4% -$134K 0.07% 269
2014
Q3
$3.69M Sell
52,470
-3,130
-6% -$207K 0.07% 268
2014
Q2
$3.16M Sell
55,600
-90
-0.2% -$4.75K 0.06% 296
2014
Q1
$2.9M Sell
55,690
-5,220
-9% -$260K 0.05% 307
2013
Q4
$2.91M Buy
60,910
+3,320
+6% +$153K 0.05% 308
2013
Q3
$2.46M Sell
57,590
-37,700
-40% -$1.47M 0.05% 330
2013
Q2
$3.44M Buy
+95,290
New +$3.69M 0.07% 296

Other funds holding HCA

Nomura Asset Management's HCA Position: Q1 2026 in Review

Nomura Asset Management increased its HCA Healthcare (HCA) stake by 1.5% in Q1 2026, buying an estimated $501K and bringing the position to 65,232 shares worth $30.9M. The position accounts for 0.08% of the portfolio, ranked #249.

Nomura Asset Management first reported a position in HCA in Q2 2013 and has held it in 52 quarters since. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Nomura Asset Management held 65,232 shares of HCA Healthcare worth $30.9M as of Q1 2026.
  • Nomura Asset Management bought 995 HCA Healthcare shares in Q1 2026, an estimated $501K.
  • HCA Healthcare made up 0.08% of Nomura Asset Management's portfolio in Q1 2026, its #249 holding.
  • Nomura Asset Management first reported a position in HCA Healthcare in Q2 2013 and has held it in 52 quarters since.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Nomura Asset Management's 13F filing for Q1 2026, filed 11 May 2026.